• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β2肾上腺素能受体中配体诱导的构象状态的表征

Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor.

作者信息

Kobilka B, Gether U, Seifert R, Lin S, Ghanouni P

机构信息

Howard Hughes Medical Institute, Department of Molecular and Cellular Physiology, Stanford University Medical Center, CA 94305-5345, USA.

出版信息

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):293-300. doi: 10.3109/10799899909036652.

DOI:10.3109/10799899909036652
PMID:10071765
Abstract

Drugs acting at G protein coupled receptors can be classified in biological assays as either agonists, partial agonists, neutral antagonists, or as inverse agonists. Very little is known about the actual molecular events and structural changes that occur in the receptor following ligand binding and during transmission of a signal across the membrane. Therefore, the structural basis for the biological classification of drug action remains unknown. To date, the conformational state of G protein coupled receptors has been inferred from the activity of the effector enzyme modulated by the G protein. We have used two different approaches to monitor conformational changes in beta 2 adrenergic receptor. Fluorescence spectroscopy can be used to directly monitor structural changes in purified beta 2 adrenergic receptor in real-time. The emission from many fluorescent molecules is strongly dependent on the polarity of the environment in which they are located. Thus, fluorescent probes covalently bound to proteins can be used as sensitive indicators of conformational changes and protein-protein interactions. In addition, we examined functional differences between agonists and partial agonists using fusion proteins between wild-type beta 2 receptor or a constitutively active beta 2 receptor mutant and Gs alpha. These receptor-G protein fusion proteins guarantee highly efficient coupling with a defined stoichiometry. The results of these experiments will be discussed in the context of current models of G protein coupled receptor activation.

摘要

作用于G蛋白偶联受体的药物在生物学检测中可分为激动剂、部分激动剂、中性拮抗剂或反向激动剂。关于配体结合后以及信号跨膜传递过程中受体实际发生的分子事件和结构变化,我们了解得很少。因此,药物作用生物学分类的结构基础仍然未知。迄今为止,G蛋白偶联受体的构象状态是根据由G蛋白调节的效应酶的活性推断出来的。我们采用了两种不同的方法来监测β2肾上腺素能受体的构象变化。荧光光谱可用于实时直接监测纯化的β2肾上腺素能受体的结构变化。许多荧光分子的发射强烈依赖于它们所处环境的极性。因此,与蛋白质共价结合的荧光探针可作为构象变化和蛋白质 - 蛋白质相互作用的敏感指标。此外,我们使用野生型β2受体或组成型活性β2受体突变体与Gsα之间的融合蛋白研究了激动剂和部分激动剂之间的功能差异。这些受体 - G蛋白融合蛋白保证了以确定的化学计量比进行高效偶联。这些实验的结果将在G蛋白偶联受体激活的当前模型背景下进行讨论。

相似文献

1
Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor.β2肾上腺素能受体中配体诱导的构象状态的表征
J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):293-300. doi: 10.3109/10799899909036652.
2
Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.完全激动剂与部分激动剂之间的功能差异:配体特异性受体构象的证据
J Pharmacol Exp Ther. 2001 Jun;297(3):1218-26.
3
Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.通过监测海肾荧光素酶标记的组成型活性突变体G蛋白偶联受体的选择性稳定来检测受体配体。
Br J Pharmacol. 2001 May;133(2):315-23. doi: 10.1038/sj.bjp.0704077.
4
Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.人类β1和β2肾上腺素能受体与异丙肾上腺素、肾上腺素、去甲肾上腺素及多巴胺的不同相互作用。
J Pharmacol Exp Ther. 2008 Dec;327(3):760-9. doi: 10.1124/jpet.108.143412. Epub 2008 Sep 4.
5
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.激动剂诱导的牛视紫红质构象变化:深入了解G蛋白偶联受体的激活
J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.
6
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.G蛋白偶联受体工程为β2肾上腺素能受体功能带来了高分辨率的结构见解。
Science. 2007 Nov 23;318(5854):1266-73. doi: 10.1126/science.1150609. Epub 2007 Oct 25.
7
Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor.通过与β-肾上腺素能受体融合对G蛋白Gαs的非棕榈酰化突变体的功能相互作用进行部分挽救。
Biochemistry. 2003 Mar 11;42(9):2607-15. doi: 10.1021/bi026470i.
8
Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.肾上腺素能受体中配体结合及特异性的结构基础:对G蛋白偶联受体靶向药物发现的启示
Biochemistry. 2008 Oct 21;47(42):11013-23. doi: 10.1021/bi800891r. Epub 2008 Sep 27.
9
Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.蛋白激酶A介导β2-肾上腺素能受体与不同G蛋白偶联的转换
Nature. 1997 Nov 6;390(6655):88-91. doi: 10.1038/36362.
10
Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.纯化的β2肾上腺素能受体的荧光标记。配体特异性构象变化的证据。
J Biol Chem. 1995 Nov 24;270(47):28268-75. doi: 10.1074/jbc.270.47.28268.

引用本文的文献

1
Probing the correlation between ligand efficacy and conformational diversity at the α-adrenoreceptor reveals allosteric coupling of its microswitches.探究α-肾上腺素受体配体效能与构象多样性之间的相关性揭示了其微动开关的变构偶联。
J Biol Chem. 2020 May 22;295(21):7404-7417. doi: 10.1074/jbc.RA120.012842. Epub 2020 Apr 17.